Overview
MetLife Q3 2025 revenue missed analyst expectations
Adjusted EPS for Q3 2025 beats analyst expectations
Company returned $875 mln to shareholders via repurchases and dividends
Outlook
Company did not provide specific guidance for future quarters in its press release
Result Drivers
VARIABLE INVESTMENT INCOME - Higher private equity returns significantly boosted variable investment income, contributing to a 15% increase in adjusted earnings
PENSION RISK TRANSFERS - Secured $12 bln in pension risk transfer mandates in Q4, enhancing future revenue potential
ASIA SALES GROWTH - Asia sales grew 34% on a constant currency basis, driven by new retirement-oriented products in Japan and other markets
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$17.36 bln
$18.81 bln (6 Analysts)
Q3 Adjusted EPS
Beat
$2.37
$2.32 (15 Analysts)
Q3 EPS
$1.22
Q3 Adjusted Net Income
$1.58 bln
Q3 Net Income
$818 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for MetLife Inc is $95.50, about 16.8% above its November 4 closing price of $79.46
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nBw94T4ZLa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)